[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@BioStocks](/creator/twitter/BioStocks)
"$ABBV AbbVie Announces Positive Topline Results from Second Phase X UP-AA Trial Evaluating Upadacitinib for Alopecia Areata"  
[X Link](https://x.com/BioStocks/status/1958507676884779240) [@BioStocks](/creator/x/BioStocks) 2025-08-21T12:33Z 69.9K followers, 4273 engagements


"$IMAB Completes Enrollment in Phase 1b Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers. Topline data expected in Q1"  
[X Link](https://x.com/BioStocks/status/1954863429866377460) [@BioStocks](/creator/x/BioStocks) 2025-08-11T11:12Z 69.9K followers, 3759 engagements


"$VNDA Federal appeals court overturns FDA denial of Vanda's jet lag drug HETLIOZ"  
[X Link](https://x.com/BioStocks/status/1957410701087011252) [@BioStocks](/creator/x/BioStocks) 2025-08-18T11:54Z 69.9K followers, 15.8K engagements


"$LTRN halted"  
[X Link](https://x.com/BioStocks/status/1967928085925466531) [@BioStocks](/creator/x/BioStocks) 2025-09-16T12:26Z 69.9K followers, 3942 engagements


"$IOBT Provides Update Following Pre-BLA Meeting with FDA FDA recommends not submitting BLA based on the data from the IOB-013 clinical trial. Plans to design new registrational study for Cylembio XX% workforce reduction"  
[X Link](https://x.com/BioStocks/status/1972619384368800002) [@BioStocks](/creator/x/BioStocks) 2025-09-29T11:08Z 69.9K followers, 4133 engagements


"$OVID $175M Private Placement. Janus Henderson RA Capital Eventide Asset Management Coastlands Capital Blue Owl Healthcare Opportunities Balyasny Asset Management Saturn V Capital and Ally Bridge Group ADAR1 Capital and Affinity Healthcare"  
[X Link](https://x.com/BioStocks/status/1974069025098371338) [@BioStocks](/creator/x/BioStocks) 2025-10-03T11:08Z 69.9K followers, 10.1K engagements


"$AMGN announced the launch of AmgenNow a new direct-to-patient program starting with Repatha. Eligible Patients Can Access Repatha at Nearly XX% Discount from the List Price"  
[X Link](https://x.com/BioStocks/status/1975185190734500177) [@BioStocks](/creator/x/BioStocks) 2025-10-06T13:03Z 69.9K followers, 3742 engagements


"$BIIB and Eisai Announce U.S. Availability of LEQEMBI IQLIK Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease"  
[X Link](https://x.com/BioStocks/status/1975298202976067786) [@BioStocks](/creator/x/BioStocks) 2025-10-06T20:32Z 69.9K followers, 4550 engagements


"$GUTS Announces Potent Preclinical Results from RJVA-002 a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity. RJVA-002 achieved XX% weight loss at five weeks in a translational obesity model; weight loss not yet plateaued"  
[X Link](https://x.com/BioStocks/status/1975516891826241765) [@BioStocks](/creator/x/BioStocks) 2025-10-07T11:01Z 69.9K followers, 10.7K engagements


"$BMEA offering priced at $2.05"  
[X Link](https://x.com/BioStocks/status/1975542417668648964) [@BioStocks](/creator/x/BioStocks) 2025-10-07T12:43Z 69.9K followers, 4538 engagements


"$OVID initiated with an Outperform at Oppenheimer. PT $7"  
[X Link](https://x.com/BioStocks/status/1976049626735374743) [@BioStocks](/creator/x/BioStocks) 2025-10-08T22:18Z 69.9K followers, 18.9K engagements


"$MDGL PT raised to $XXX at Oppenheimer"  
[X Link](https://x.com/BioStocks/status/1976615133993480360) [@BioStocks](/creator/x/BioStocks) 2025-10-10T11:45Z 69.9K followers, 5390 engagements


"$NVO Halts Cell Therapy Work on Diabetes to Cut Costs Almost all of the division's about XXX employees are expected to be laid off"  
[X Link](https://x.com/BioStocks/status/1976742032090538285) [@BioStocks](/creator/x/BioStocks) 2025-10-10T20:10Z 69.9K followers, 6983 engagements


"$RCUS Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed XXXX Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase X EDGE-Gastric Study. $GILD"  
[X Link](https://x.com/BioStocks/status/1977506415422976294) [@BioStocks](/creator/x/BioStocks) 2025-10-12T22:47Z 69.9K followers, 14K engagements


"$CRVS initiated with an Overweight at Barclays. PT $16"  
[X Link](https://x.com/BioStocks/status/1977677628447535332) [@BioStocks](/creator/x/BioStocks) 2025-10-13T10:07Z 69.9K followers, 13.3K engagements


"JPMorgan to Invest $10B in U.S. Co's Critical to National Security. $JPM It has become painfully clear that the United States has allowed itself to become too reliant on unreliable sources of critical minerals products and manufacturing all of which are essential for our national security" Jamie Dimon"  
[X Link](https://x.com/BioStocks/status/1977681030971556083) [@BioStocks](/creator/x/BioStocks) 2025-10-13T10:21Z 69.9K followers, 6809 engagements


"$PGEN Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS. XX out of XX complete responders (83%) demonstrate continued complete response with median follow-up of XX months"  
[X Link](https://x.com/BioStocks/status/1977691664031310230) [@BioStocks](/creator/x/BioStocks) 2025-10-13T11:03Z 69.9K followers, 8265 engagements


"$ANAB Announces Late-Breaking Presentation of Complete Phase 2b Data for Rosnilimab in RA at #ACR25"  
[X Link](https://x.com/BioStocks/status/1977725473690968536) [@BioStocks](/creator/x/BioStocks) 2025-10-13T13:17Z 69.9K followers, 3767 engagements


"Oh man Talk about bad timing. 😬 $TVRD covg initiated with an Overweight at Barclays. PT $61"  
[X Link](https://x.com/BioStocks/status/1977729676563857649) [@BioStocks](/creator/x/BioStocks) 2025-10-13T13:34Z 69.9K followers, 10.8K engagements


"$DNLI Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome) PDUFA extended from Jan X 2026 to April X 2026"  
[X Link](https://x.com/BioStocks/status/1977833297247187353) [@BioStocks](/creator/x/BioStocks) 2025-10-13T20:26Z 69.9K followers, 5829 engagements


"$BIIB LEQEMBI IQLIK Subcutaneous Autoinjector Named to TIMEs Best Inventions of 2025"  
[X Link](https://x.com/BioStocks/status/1977890086587928656) [@BioStocks](/creator/x/BioStocks) 2025-10-14T00:11Z 69.9K followers, 4082 engagements


"$SYRE prices $275M offering. 14.86M shares at $18.50/share"  
[X Link](https://x.com/BioStocks/status/1977904557779722403) [@BioStocks](/creator/x/BioStocks) 2025-10-14T01:09Z 69.9K followers, 5342 engagements


"$BCRX $ATXS halted"  
[X Link](https://x.com/BioStocks/status/1978052566903615599) [@BioStocks](/creator/x/BioStocks) 2025-10-14T10:57Z 69.9K followers, 13.3K engagements


"$BCRX to acquire $ATXS for $XXXX in cash and XXXX shares of BioCryst common stock"  
[X Link](https://x.com/BioStocks/status/1978053749495988231) [@BioStocks](/creator/x/BioStocks) 2025-10-14T11:02Z 69.9K followers, 20.2K engagements


"$MDGL initiated with a Buy at Truist. PT $580"  
[X Link](https://x.com/BioStocks/status/1978237485869052296) [@BioStocks](/creator/x/BioStocks) 2025-10-14T23:12Z 69.9K followers, 5007 engagements


"$LLY oral GLP-1 Orforglipron demonstrated superior glycemic control in two successful Phase X trials reconfirming its potential as a foundational treatment in type X diabetes. $VKTX"  
[X Link](https://x.com/BioStocks/status/1978412114155917339) [@BioStocks](/creator/x/BioStocks) 2025-10-15T10:46Z 69.9K followers, 10.4K engagements


"$MDGL PT raised to $XXX at Piper"  
[X Link](https://x.com/BioStocks/status/1978414790797095275) [@BioStocks](/creator/x/BioStocks) 2025-10-15T10:56Z 69.9K followers, 4292 engagements


"$CDTX initiated with an Overweight at Morgan Stanley. PT $190"  
[X Link](https://x.com/BioStocks/status/1978763387040317545) [@BioStocks](/creator/x/BioStocks) 2025-10-16T10:02Z 69.9K followers, 9907 engagements


"$GMAB updated data from the Phase 1/2 RAINFOL-01 trial showed rinatabart sesutecan XXX mg/m2 demonstrated XX% confirmed ORR including two CRs regardless of FR expression. #ESMO25"  
[X Link](https://x.com/BioStocks/status/1979499006674747541) [@BioStocks](/creator/x/BioStocks) 2025-10-18T10:45Z 69.9K followers, 4495 engagements


"$PASG 1-for-20 Reverse Split"  
[X Link](https://x.com/BioStocks/status/1943264531716677964) [@BioStocks](/creator/x/BioStocks) 2025-07-10T11:02Z 69.9K followers, 3139 engagements


"$ROIV and Priovant Announce Positive Phase X VALOR Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis (DM)"  
[X Link](https://x.com/BioStocks/status/1968269093494214915) [@BioStocks](/creator/x/BioStocks) 2025-09-17T11:01Z 69.9K followers, 9656 engagements


"Bristol Myers Takeda to pool data for AI-based drug discovery. $BMY $TAK $RXRX $ABSI"  
[X Link](https://x.com/BioStocks/status/1973358455030518040) [@BioStocks](/creator/x/BioStocks) 2025-10-01T12:04Z 69.9K followers, 8067 engagements


"$SPRB Receives FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB)"  
[X Link](https://x.com/BioStocks/status/1975169574208196778) [@BioStocks](/creator/x/BioStocks) 2025-10-06T12:01Z 69.9K followers, 4497 engagements


"$GDRX And $AMGN Partner To Offer Repatha Nationwide For $239"  
[X Link](https://x.com/BioStocks/status/1975191726772883942) [@BioStocks](/creator/x/BioStocks) 2025-10-06T13:29Z 69.9K followers, 10.7K engagements


"$LLY In ACHIEVE-2 Orforglipron lowered A1C by up to XXX% compared to XXX% with dapagliflozin meeting the primary endpoint In ACHIEVE-5Orforglipron lowered A1C by an additional XXX% when taken with insulin glargine meeting the primary endpoint"  
[X Link](https://x.com/BioStocks/status/1978412309144867017) [@BioStocks](/creator/x/BioStocks) 2025-10-15T10:47Z 69.9K followers, 5936 engagements


"$ABSI to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on Dec XX. Announces Accelerated Initiation of Phase 1/2a Trial"  
[X Link](https://x.com/BioStocks/status/1978434376976228756) [@BioStocks](/creator/x/BioStocks) 2025-10-15T12:14Z 69.9K followers, 3997 engagements


"$OMER and $NVO announce asset purchase and license agreement for Omeros clinical-stage MASP-3 inhibitor zaltenibart. $340M upfront"  
[X Link](https://x.com/BioStocks/status/1978442594939015310) [@BioStocks](/creator/x/BioStocks) 2025-10-15T12:47Z 69.9K followers, 15.1K engagements


"@oncinvestor @PersimmonTI"  
[X Link](https://x.com/BioStocks/status/1978601491414855878) [@BioStocks](/creator/x/BioStocks) 2025-10-15T23:18Z 69.9K followers, XXX engagements


"$IRON Receives FDA Commissioners National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)"  
[X Link](https://x.com/BioStocks/status/1978954065301151820) [@BioStocks](/creator/x/BioStocks) 2025-10-16T22:39Z 69.9K followers, 7342 engagements


"$VOR Late-Breaking Presentation of China Phase X IgA Nephropathy Clinical Study at #ASN25"  
[X Link](https://x.com/BioStocks/status/1979156700000043479) [@BioStocks](/creator/x/BioStocks) 2025-10-17T12:05Z 69.9K followers, 3265 engagements


"$LLY Verzenio (abemaciclib) prolonged survival in HR+ HER2- high-risk early breast cancer with two years of treatment. Two years of adjuvant Verzenio plus endocrine therapy (ET) reduced the risk of death by XXXX% versus ET alone"  
[X Link](https://x.com/BioStocks/status/1979158700397895725) [@BioStocks](/creator/x/BioStocks) 2025-10-17T12:12Z 69.9K followers, 4064 engagements


"$PTGX PT raised to $XX at Citi. $JNJ"  
[X Link](https://x.com/BioStocks/status/1979137048180047876) [@BioStocks](/creator/x/BioStocks) 2025-10-17T10:46Z 69.9K followers, 9713 engagements


"$MRK an objective response rate of XXXX% was observed with Raludotatug Deruxtecan across all dose levels in the Phase X Part of REJOICE-Ovarian01 Phase 2/3 Trial. #ESMO25"  
[X Link](https://x.com/BioStocks/status/1979894161445908786) [@BioStocks](/creator/x/BioStocks) 2025-10-19T12:55Z 69.9K followers, 4268 engagements